Guo-ming Chen

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Cellular senescence in gastric cancer: a novel prognostic stratification and immune predictor.

Cellular senescence in gastric cancer: a novel prognostic stratification and immune predictor.

Journal: BMC medical genomics
Published: January 06, 2026

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.

Journal: Cell reports. Medicine
Published: January 14, 2025

Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.

Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.

Journal: Molecular cancer
Published: July 16, 2024

Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer.

Hyperactivation of mTOR/eIF4E Signaling Pathway Promotes the Production of Tryptophan-To-Phenylalanine Substitutants in EBV-Positive Gastric Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 03, 2024

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis.

Prognostic Significance of PD-L1 Expression in Gastric Cancer Patients with Peritoneal Metastasis.

Journal: Biomedicines
Published: May 16, 2023

ASO Author Reflections: The Role of Adjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction.

ASO Author Reflections: The Role of Adjuvant Chemotherapy in Adenocarcinoma of the Esophagogastric Junction.

Journal: Annals of surgical oncology
Published: November 14, 2022

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials.

LAG3-PD1 or CTLA4-PD1 Inhibition in Advanced Melanoma: Indirect Cross Comparisons of the CheckMate-067 and RELATIVITY-047 Trials.

Journal: Cancers
Published: September 08, 2022

Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter, Observational Study.

Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter, Observational Study.

Journal: Annals of surgical oncology
Published: June 02, 2022

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.

Journal: BMC cancer
Published: December 20, 2020

ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery.

ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery.

Journal: Annals of surgical oncology
Published: May 01, 2020

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis.

Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis.

Journal: Frontiers in oncology
Published: March 02, 2020

Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer.

Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer.

Journal: Annals of surgical oncology
Published: October 09, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026